A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area
PHASE1
This is a trial to evaluate the safety and immunogenicity of double mutant ...
Status
Terminated
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
PHASE2
This phase II MyeloMATCH treatment trial compares the effect of adding vene...